Section Arrow
ACLX.NASDAQ
- Arcellx
Quotes are at least 15-min delayed:2025/07/17 02:10 EDT
Regular Hours
Last
 70.7
+2.55 (+3.74%)
Day High 
70.86 
Prev. Close
68.15 
1-M High
70.81 
Volume 
388.02K 
Bid
50
Ask
84.7
Day Low
68.34 
Open
68.8 
1-M Low
60.92 
Market Cap 
3.76B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 67.52 
20-SMA 65.8 
50-SMA 63.63 
52-W High 107.3699 
52-W Low 47.8601 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.99/-4.22
Enterprise Value
3.80B
Balance Sheet
Book Value Per Share
7.57
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
107.94M
Operating Revenue Per Share
0.58
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
APMAptorum Group Limited1.94+0.9702+100.04%2.77PE
TNFATNF Pharmaceuticals Inc.0.109+0.0028+2.64%-- 
NCNANuCana plc0.0502--0.000%-- 
BRNSBarinthus Biotherapeutics plc1.42+0.4+39.22%-- 
WINTWindtree Therapeutics Inc.0.9+0.0714+8.62%0.84PE
Quotes are at least 15-min delayed:2025/07/17 02:10 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.